HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.

Blood
Anna Smed-SörensenAnna-Lena Spetz

Abstract

Dendritic cells (DCs) are antigen-presenting cells with the capacity to prime naive T cells for efficient cellular responses against pathogens such as HIV-1. DCs are also susceptible to HIV-1 infection, which may impair their ability to induce immunity. Here, we examined the ability of HIV-1-infected, in vitro-derived DCs to respond to CD40 ligand (CD40L) stimulation with the aim to study events during early HIV-1 infection. HIV-1(BaL)-infected p24(+) DCs were detected after only 3 days of exposure to highly concentrated virus. We show that HIV-1-infected DCs up-regulated costimulatory molecules, but were skewed in their production of effector cytokines in response to CD40L stimulation. CD40L stimulation induced significant secretion of tumor necrosis factor alpha (TNFalpha) and interleukin 12 (IL-12) p70 from both HIV-1-exposed and unexposed DCs. Intracellular stainings of HIV-1-exposed DCs revealed that TNFalpha could be detected in both the p24(-) and p24(+) DCs, but IL-12 p70 could be found only in the p24(-) DCs. Thus, although p24(+) DCs showed a mature phenotype similar to p24(-) DCs after CD40L stimulation, they appeared to have an impaired cytokine profile. These observations suggest that HIV-1 infection disables DC fu...Continue Reading

Associated Clinical Trials

Feb 25, 2014·Nina Bhardwaj, Nina Bhardwaj

References

Nov 1, 1995·The Journal of Experimental Medicine·P GarroneJ Banchereau
Apr 1, 1994·The Journal of Experimental Medicine·J ChehimiG Trinchieri
Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Feb 4, 1993·The New England Journal of Medicine·G PantaleoA S Fauci
Feb 26, 1993·Journal of Immunological Methods·T JungC Rieger
Jan 1, 1996·Annual Review of Immunology·A S Baldwin
Jan 1, 1997·Advances in Experimental Medicine and Biology·R M SteinmanK Inaba
Apr 1, 1998·European Journal of Immunology·C ChougnetG M Shearer
Apr 1, 1998·Nature·J Banchereau, R M Steinman
May 23, 1998·Annual Review of Immunology·S GhoshE B Kopp
Aug 12, 1999·Clinical and Experimental Immunology·G VanhamJ L Ceuppens
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C Servet-DelpratC Rabourdin-Combe
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S EbnerN Romani
Jun 9, 2001·The Journal of Infectious Diseases·S F AtabaniC L Karp
Oct 19, 2001·Oncogene·J R Bradley, J S Pober
Jul 27, 2002·Journal of Immunotherapy·Hélène RouardMarie-Hélène Delfau-Larue
Jan 11, 2003·Clinical and Diagnostic Laboratory Immunology·Wilco de JagerGer T Rijkers
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tatsuyoshi KawamuraAndrew Blauvelt
Jun 28, 2003·Blood·Alison SmithPaolo Lusso
Sep 11, 2003·Journal of Medical Virology·Anders MalmstenJ Simon Gronowitz

❮ Previous
Next ❯

Citations

Dec 21, 2004·Springer Seminars in Immunopathology·Marie Larsson
Mar 9, 2006·Current HIV/AIDS Reports·Susanna Grundström, Jan Andersson
May 22, 2007·Nature Immunology·Anthony L CunninghamHeather Donaghy
Jun 22, 2005·The Journal of Experimental Medicine·Karin LoréRichard A Koup
Mar 15, 2011·The Journal of Infectious Diseases·Feng QianRuth R Montgomery
Aug 21, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Elizabeth A MillerNina Bhardwaj
Nov 7, 2007·PLoS Pathogens·Meimei ShanJohn P Moore
Jul 7, 2011·PLoS Pathogens·Mireille LaforgeJérôme Estaquier
Jul 11, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Laurence VachotMelissa Robbiani
Jan 1, 2006·Current Opinion in HIV and AIDS·Stuart G TurvilleMelissa Pope
Jul 12, 2011·Current Opinion in HIV and AIDS·Anna Smed-Sörensen, Karin Loré
Aug 22, 2014·Expert Opinion on Biological Therapy·Elizabeth Miller, Nina Bhardwaj
Dec 3, 2014·The Lancet Infectious Diseases·Michaëla A M HusonTom van der Poll
May 5, 2010·Immunobiology·Ulrika JohanssonAnna-Lena Spetz
Jul 7, 2009·Journal of Theoretical Biology·Shingo IwamiYasuhiro Takeuchi
May 12, 2009·Immunology Letters·Shingo IwamiTomoyuki Miura
Jul 28, 2005·International Journal of Experimental Pathology·Gabriele PollaraDavid R Katz
Sep 16, 2006·Immunological Reviews·Yuri Persidsky, Larisa Poluektova
Sep 5, 2012·Clinical and Experimental Immunology·P Fairman, J B Angel
Aug 3, 2013·Reviews in Medical Virology·Andrew N HarmanPaul U Cameron
May 11, 2010·European Journal of Immunology·Karlhans F CheMarie Larsson
Jun 19, 2013·Immunological Reviews·Elizabeth Miller, Nina Bhardwaj
Mar 11, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Silvia Della BellaMaria Luisa Villa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.